| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.5 | 0.08 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.31 | 0.3 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.25 | 0.4 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.21 | 0.5 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.003 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.16 | 0.006 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.15 | 0.008 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.15 | 0.008 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.1 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |